Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Quispe Cabanillas, Juan G ^a   Damasceno, Alfredo ^a   von Glehn, Felipe ^a   Brandão, Carlos O ^a   Damasceno, Benito P ^a   Silveira, Wanderley D ^a   Santos, Leonilda M B ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chinese traditional medicine; Depression; Electroacupuncture; Expanded disability status scale; Multiple sclerosis; Pain; Quality of life; Randomised control trial; Symptoms

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; GLATIRAMER; IMMUNOMODULATING AGENT; INTERFERON BETA SERINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; ELECTROACUPUNCTURE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF MULTIPLE SCLEROSIS; HUMAN; MALE; MULTIPLE SCLEROSIS; PAIN; PHYSICIAN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT; SEX DIFFERENCE; SHAM PROCEDURE; SYMPTOM; THERAPY EFFECT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VISUAL ANALOG SCALE;

ADULT; COMBINED MODALITY THERAPY; ELECTROACUPUNCTURE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868262737     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-209     Document Type: Article

References (39)

1. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple Sclerosis: risk factors, prodromes and potential causal pathways. Lancet Neurol 2010, 9:727-739. 10.1016/S1474-4422(10)70094-6, 20610348.
2. Giovannoni G. Promising emerging therapies for multiple sclerosis. Neurol Clin 2011, 29(2):435-448. 10.1016/j.ncl.2011.01.003, 21439452.
3. Schluep M, Bogousslavsky J. Emerging treatments in multiple sclerosis. Eur Neurol 1997, 38(3):216-221. 10.1159/000113376, 9363834.
4. Young RR. Diagnosis and medical management of multiple sclerosis. J Spinal Cord Med 1998, 21(2):109-112.
5. Garcia-Moreno JM, Navarro G, Duque P, Gamero MA, Gata JM, Gálvez JL, Izquierdo G. Evolution and adverse effects in patients with remittent-recurrent multiple sclerosis treated with interferon beta 1b. The influence of patient's weight and height. Neurologia 1999, 14(4):154-158.
6. Olascoaga J. Calidad de vida y esclerosis múltiple. Rev Neurol 2010, 51:279-288.
7. Ulett GA, Han S, Han JS. Electroacupuncture: mechanisms and clinical application. Biol Psychiatry 1998, 44(2):129-138. 10.1016/S0006-3223(97)00394-6, 9646895.
8. Aranha MF, Alves MC, Bérzin F, Gavião MB. Efficacy of electroacupuncture for myofascial pain in the upper trapezius muscle: a case series. Rev Bras Fisioter 2011, 15(5):371-379. 10.1590/S1413-35552011005000022, 22002184.
9. Gakiya HH, Silva DA, Gomes J, Stevanin H, Cassu RN. Electroacupuncture versus morphine for the postoperative control pain in dogs. Acta Cir Bras 2011, 26(5):346-351. 10.1590/S0102-86502011000500004, 21952656.
10. Wu P, Mills E, Moher D, Seely D. Acupuncture in poststroke rehabilitation: a systematic review and meta-analysis of randomized trials. Stroke 2010, 41(4):171-179.
11. Zhang F, Wu Y, Jia J. Electro-acupuncture can alleviate the cerebral edema of rat after ischemia. Brain Inj 2011, 25(9):895-900. 10.3109/02699052.2011.581639, 21699400.
12. Cheng XK, Wang ZM, Sun L, Li YH. Post-stroke hand dysfunction treated with acupuncture at Zhongzhu (TE 3) and Waiguan (TE 5). Zhongguo Zhen Jiu 2011, 31(2):117-120.
13. Donnellan CP, Shanley J. Comparison of the effect of two types of acupuncture on quality of life in secondary progressive multiple sclerosis: a preliminary single-blind randomized controlled trial. Clin Rehabil 2008, 22(3):195-205.
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, Van Den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127. 10.1002/ana.1032, 11456302.
15. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol 2010, 69:292-302.
16. Kavoussi B, Ross BE. The neuroimmune basis of anti-inflammatory acupuncture. Integr Cancer Ther 2007, 6(3):251-257. 10.1177/1534735407305892, 17761638.
17. Joos S, Schott C, Zou H, Daniel V, Martin E. Immunomodulatory effects of acupuncture in the treatment of allergic asthma: a randomized controlled study. J Altern Complement Med 2000, 6(6):519-525. 10.1089/acm.2000.6.519, 11152056.
18. Yamaguchi N, Takahashi T, Sakuma M, Sugita T, Uchikawa K, Sakaihara S, Kanda T, Arai M, Kawakita K. Acupuncture regulates leukocyte subpopulations in human peripheral blood. Evid Based Complement Alternat Med 2007, 4(4):447-453. 10.1093/ecam/nel107, 2176150, 18227912.
19. Chang CH, Huang JL, Ting CT, Chang CS, Chen GH. Atropine-induced HRV alteration is not amended by electroacupuncture on Zusanli. Am J Chin Med 2005, 33(2):307-314. 10.1142/S0192415X05002928, 15974489.
20. Li A, Lao L, Wang Y, Xin J, Ren K, Berman BM, Tan M, Zhang R. Electroacupuncture activates corticotrophin-releasing hormone-containing neurons in the paraventricular nucleus of the hypothalammus to alleviate edema in a rat model of inflammation. BMC Complement Altern Med 2008, 8:20. 10.1186/1472-6882-8-20, 2408560, 18474100.
21. Mori H, Nishijo K, Kawamura H, Abo T. Unique immunomodulation by electro-acupuncture in humans possibly via stimulation of the autonomic nervous system. Neurosci Lett 2002, 320(1-2):21-24.
22. Ding L. Acupuncture, Meridian Theory and Acupuncture Points 1970, Beijing: Foreing Languages Press.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33(11):1444-1452. 10.1212/WNL.33.11.1444, 6685237.
24. Mendes MF, Balsimelli S, Stangehaus G, TILBERY CP. Validação de escala de determinação funcional da qualidade de vida na esclerose múltipla para a língua portuguesa. Arq Neuro-Psiquiatr 2004, 62(1):108-113.
25. Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, Chang C, Lloyd S, Steward J, Stefoski D. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996, 47:129-139. 10.1212/WNL.47.1.129, 8710066.
26. Bermejo PE, Oreja-Guevara C, Díez-Tejedor E. El dolor en la esclerosis múltiple: prevalencia, mecanismos, tipos y tratamiento. Rev Neurol 2010, 50:101-108.
27. Osborne TL, Jensen MP, Ehde DM, Hanley MA, Kraft G. Psychosocial factors associated with pain intensity, pain-related interference, and psychological functioning in persons with multiple sclerosis and pain. Pain 2007, 127(1-2):52-62.
28. Kalia LV, O'Connor PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler 2005, 11(3):322-327. 10.1191/1352458505ms1168oa, 15957515.
29. Ehde DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH. The scope and nature of pain in persons with multiple sclerosis. Mult Scler 2006, 12(5):629-638. 10.1177/1352458506071346, 17086910.
30. Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005, 114(3):473-481. 10.1016/j.pain.2005.01.015, 15777872.
31. Zhao ZQ. Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 2008, 85:355-375. 10.1016/j.pneurobio.2008.05.004, 18582529.
32. Han JS, Ho YS. Global trends and performances of acupuncture research. Neruosci Biobehav Rev 2011, 35:680-687.
33. Han JS, Terenius L. Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol 1982, 22:91-104.
34. Marx JL. Analgesia: how the body inhibits pain perception. Science 1977, 196:471.
35. Mayer DJ, Price DD, Raffii A. Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxine. Brain Res 1977, 121:368-372. 10.1016/0006-8993(77)90161-5, 832169.
36. Pomeranz B, Chiu D. Naloxone blocks acupuncture analgesia and causes hyperalgesia: endorphin is implicated. Life Sci 1976, 19:1757-1762. 10.1016/0024-3205(76)90084-9, 187888.
37. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002, 205(1):51-58. 10.1016/S0022-510X(02)00312-X, 12409184.
38. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan V, Dubey N, Kinkel PR. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000, 6(3):181-185.
39. Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 2009, 277(1):37-41. 10.1016/j.jns.2008.10.009, 19036389.